Form 4: uniQure Director Sells Shares to Cover Tax Obligations

A director at uniQure N.V. sold 2,112 ordinary shares for $14.45 per share to cover estimated withholding taxes upon the vesting of restricted share units.

Summary

• Rachelle Suzanne Jacques, a Director of uniQure N.V. (QURE), reported a transaction on June 20, 2025.
• The transaction involved the sale of 2,112 ordinary shares.
• The shares were sold at a weighted average price of $14.45 per share, with individual transactions ranging from $14.40 to $14.50.
• The sale was explicitly stated as non-discretionary, executed solely to cover estimated withholding taxes upon the vesting of restricted share units, pursuant to automatic sale instructions.
• Following this transaction, Rachelle Suzanne Jacques beneficially owns 28,346 ordinary shares directly.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary sale of shares to cover tax obligations upon the vesting of restricted share units, which is a routine event and does not indicate a change in management's confidence or outlook, thus rendering a neutral sentiment.

Positives

• The sale was non-discretionary and solely for tax purposes, indicating it does not reflect a change in the director's confidence in the company's future.

Negatives

• The transaction resulted in a reduction of the director's direct beneficial ownership by 2,112 shares.

Risks

• No specific new risks are identified in this Form 4 filing beyond the routine nature of insider transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• "The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."

Industry Context

SEC Form 4 filings are routine disclosures for publicly traded companies, reporting changes in beneficial ownership by insiders. This specific transaction, a non-discretionary sale to cover tax obligations upon RSU vesting, is a common occurrence in the biotechnology and pharmaceutical industry, where equity compensation is a standard practice for executives and directors.

Comparison to Industry Standards

• This transaction is a standard compliance filing for insider trading, common across all industries, and does not provide specific comparable company or project results.
• The nature of the sale (tax-related, non-discretionary) aligns with common practices for equity compensation vesting among executives in publicly traded companies globally.

Related Party Transactions

• The reported transaction itself is a related party transaction, involving a director's sale of company shares.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, but its non-discretionary nature for tax purposes mitigates concerns about insider sentiment or future company performance.

Next Steps

• No specific future actions, events, or milestones are mentioned in this compliance filing.

Key Dates

Recommendation

Keywords

uniQure, QURE, SEC Form 4, insider transaction, share sale, director, restricted share units, tax obligations, beneficial ownership